Peoples GE - Search Results

1

Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.

Kuerer HM, Peoples GE, Sahin AA, Murray JL, Singletary SE, Castilleja A, Hunt KK, Gershenson DM, Ioannides CG. Kuerer HM, et al. Among authors: peoples ge. J Interferon Cytokine Res. 2002 May;22(5):583-92. doi: 10.1089/10799900252982061. J Interferon Cytokine Res. 2002. PMID: 12060497

2

Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides.

Peoples GE, Anderson BW, Fisk B, Kudelka AP, Wharton JT, Ioannides CG. Peoples GE, et al. Ann Surg Oncol. 1998 Dec;5(8):743-50. doi: 10.1007/BF02303486. Ann Surg Oncol. 1998. PMID: 9869522

3

Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer.

Heaton KM, Peoples GE, Singletary SE, Feig BW, Ross MI, Ames FC, Buchholz TA, Strom EA, McNeese MD, Hunt KK. Heaton KM, et al. Among authors: peoples ge. Ann Surg Oncol. 1999 Jan-Feb;6(1):102-8. doi: 10.1007/s10434-999-0102-8. Ann Surg Oncol. 1999. PMID: 10030422

4

Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.

Peoples GE, Anderson BW, Lee TV, Murray JL, Kudelka AP, Wharton JT, Ioannides CG. Peoples GE, et al. Clin Cancer Res. 1999 Dec;5(12):4214-23. Clin Cancer Res. 1999. PMID: 10632363

5

Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients.

Kim DK, Lee TV, Castilleja A, Anderson BW, Peoples GE, Kudelka AP, Murray JL, Sittisomwong T, Wharton JT, Kim JW, Ioannides CG. Kim DK, et al. Among authors: peoples ge. Anticancer Res. 1999 Jul-Aug;19(4B):2907-16. Anticancer Res. 1999. PMID: 10652572

6

Identification of activated tumor antigen-reactive CD8+ cells in healthy individuals.

Lee TV, Anderson BW, Peoples GE, Castilleja A, Murray JL, Gershenson DM, Ioannides CG. Lee TV, et al. Among authors: peoples ge. Oncol Rep. 2000 May-Jun;7(3):455-66. doi: 10.3892/or.7.3.455. Oncol Rep. 2000. PMID: 10767352

7

Secretion of CXC chemokine IP-10 by peripheral blood mononuclear cells from healthy donors and breast cancer patients stimulated with HER-2 peptides.

Lee TV, Kim DK, Peoples GE, Castilleja A, Murray JL, Gershenson DM, Ioannides CG. Lee TV, et al. Among authors: peoples ge. J Interferon Cytokine Res. 2000 Apr;20(4):391-401. doi: 10.1089/107999000312333. J Interferon Cytokine Res. 2000. PMID: 10805374

8

Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals.

Anderson BW, Peoples GE, Murray JL, Gillogly MA, Gershenson DM, Ioannides CG. Anderson BW, et al. Among authors: peoples ge. Clin Cancer Res. 2000 Nov;6(11):4192-200. Clin Cancer Res. 2000. PMID: 11106231

9

Clinical studies of vaccines targeting breast cancer.

Ko BK, Kawano K, Murray JL, Disis ML, Efferson CL, Kuerer HM, Peoples GE, Ioannides CG. Ko BK, et al. Among authors: peoples ge. Clin Cancer Res. 2003 Aug 15;9(9):3222-34. Clin Cancer Res. 2003. PMID: 12960107 Review.

10

Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patients.

Woll MM, Fisher CM, Ryan GB, Gurney JM, Storrer CE, Ioannides CG, Shriver CD, Moul JW, McLeod DG, Ponniah S, Peoples GE. Woll MM, et al. Among authors: peoples ge. J Clin Immunol. 2004 Jul;24(4):449-61. doi: 10.1023/B:JOCI.0000029117.10791.98. J Clin Immunol. 2004. PMID: 15163902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters